Absorption Pharma soaks up talent from GSK
This article was originally published in Scrip
Absorption Pharmaceuticals has hired GlaxoSmithKline veteran, Harpreet Sheridan, as vice-president of sales. Ms Sheridan helped GSK launch many new drugs, such as Jalyn (dutasteride and tamsulosin) and Staxyn (vardenafil HCl), but was most recently urology executive sales specialist for Levitra (vardenafil). At Absorption, she will be responsible for sales of the company's first product, Promescent (buypromescent) for premature ejaculation.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.